NCT07021118

Brief Summary

Mild TBI is one of the main causes of admission to the Emergency Department (ED). Brain computed tomography (CT) is one of the most widely used diagnostic tools to assess the presence of intracranial lesions. However, in Western countries, 85-95% of CT scans performed in the ED for mild TBI are negative. It is therefore conceivable that a significant number of CTs could be avoided by a more careful use of this exam. On the other hand, excessive use of CT exposes patients to unnecessary radiation, increases healthcare costs and slows down the management of patients in the ED. This study aims to analyze the variability in the use of CT in mild TBI in Italian EDs, validate the scores designed to help the physician decide when to use it and develop a model that predicts the medium-term outcome of patients with mild head trauma.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,500

participants targeted

Target at P75+ for all trials

Timeline
16mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Sep 2025Aug 2027

First Submitted

Initial submission to the registry

May 29, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

July 2, 2025

Status Verified

May 1, 2025

Enrollment Period

12 months

First QC Date

May 29, 2025

Last Update Submit

June 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To assess the use of CT

    The heterogeneity of CT use between centers will be assessed using the Pearson chi-square test. If significant heterogeneity in the case-mix of patients between EDs emerges, this crude analysis will be supported by a standardized analysis. Specifically, the Standardized Event Ratio (SER) will be calculated for each ED, i.e. the ratio between CT performed in a center and those expected based on the characteristics of patients arriving at that ED. The number of expected CBTs will be calculated using a logistic regression model, developed on all patients enrolled in the study.

    September 2025 - August 2026

Secondary Outcomes (2)

  • Validate the most common scores

    September 2026 - August 2027

  • Develop a new score to improve existing ones.

    January 2027 - August 2027

Study Arms (1)

Elegible population

Adult patients presenting to the emergency department for mild head trauma (Glasgow Coma Scale 13-15). Patients with trauma-related loss of consciousness lasting more than 30 minutes and patients with post-traumatic amnesia lasting more than 24 hours were excluded.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients arriving in the emergency department with mild TBI (Glasgow Coma Scale 13-15). Patients with trauma-associated loss of consciousness lasting more than 30 minutes and patients with post-traumatic amnesia lasting more than 24 hours.

You may qualify if:

  • Adult patients arriving in the emergency department. Adult patients with mild TBI Adult patients with Glasgow Coma Scale 13-15.

You may not qualify if:

  • All patients under 18 years. Patients with trauma-associated loss of consciousness lasting more than 30 minutes.
  • Patients with post-traumatic amnesia lasting more than 24 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico di Milano Ospedale Maggiore

Milan, Italy

Location

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 29, 2025

First Posted

June 13, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2027

Last Updated

July 2, 2025

Record last verified: 2025-05

Locations